Vyne Therapeutics Inc. · NASDAQ:VYNE
Cormorant Asset Management, LP reported a 9.99% stake in Vyne Therapeutics Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 19, 2025
Cormorant Asset Management, LP reported a 9.99% stake in Vyne Therapeutics Inc., 1,849,590 shares, as a passive investor on Mar 31, 2025. Filed May 19, 2025 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 1,849,590
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Cormorant Asset Management, LP | 9.99% | 1,849,590 |
| Bihua Chen | 9.99% | 1,849,590 |
Source
Related
- Vyne Therapeutics Inc.
- Cormorant Asset Management, LP
- Vyne Therapeutics Inc. shareholders
- Schedule 13G/A · Cormorant Asset Management, LP · Nov 14, 2025
- Schedule 13G/A · Cormorant Asset Management, LP · Aug 14, 2025
- Schedule 13G/A · Cormorant Asset Management, LP · May 15, 2025
- Form 4 · Zeronda Tyler · Jul 24, 2026
- Form 4 · Stuart Iain · Jul 24, 2026
- Form 4 · Harsch Mutya · Jul 24, 2026
- Form 4 · Domzalski David · Jul 24, 2026
- Schedule 13G/A · Zhang Xiaofan · Jul 17, 2026